Assessment of treatment by measuring the level of eosinophylic cation protein (ECP) in the serum of children with asthma;Provjera uspješnosti liječenja mjerenjem razine eozinofilnog kationskog proteina (ECP) u serumu u djece s astmom

Paediatria Croatica

Volumn 47, Issue 3, 2003, Pages 145-148

  Zubović, Ivan ^a   Rožmanić, Vojko ^b   Ahel, Vladimir ^b   Banac, Srdan ^a  

^a KBC RIJEKA   (Croatia)

^b Klinika za Pedijatriju Kantrida ^*

Author keywords

Asthma therapy; Blood proteins analysis; Inflammation mediators blood; Treatment outcome

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; EOSINOPHIL CATIONIC PROTEIN; FLUNISOLIDE; PLASMA PROTEIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; ATOPY; CELL ACTIVATION; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE MARKER; DRUG EFFICACY; DYNAMICS; EOSINOPHIL; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; IMMUNITY; MACROPHAGE; MAST CELL; MEASUREMENT; MEDICAL ASSESSMENT; RANDOMIZATION; RESPIRATORY TRACT MUCOSA; SCORING SYSTEM; SERUM; SPIROMETRY; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TREATMENT OUTCOME; WHEEZING;

EID: 0242323694     PISSN: 13301403     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ivković-Jureković I, Lokas-Kolbas R, Linarić I. Opstrukcijski bronhitis u dojenčadi i male djece. Paediatr Croat 2000;44:107-11.
2. Bousquet J, Jeffery PK, Busse W, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-45.
3. Ferdousi H, Dreborg S. Asthma, bronchial hyper-reactivity and mediator release in children with pollinosis. ECP and EPX are not related to bronchial hyperreactivity. Clin Exp Allergy 1997;27:5300-9.
4. 2 and exacerbations. Respiratory Medicine 1994;88:613-21.
5. Vatrella A, Ponticello R, Parella L, Romano S, Zofra A, Levabariffi F. Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma. Allergy 1996;51:547.
6. Sugai T, Sakiyama Y. Eosinophil cationic protein in peripherial blood of pediatric patients with allergic diseases. Clin Exp Allergy 1992;22:275-81.
7. Sanz M. In vitro dignosis for bronchial asthma. J Invest Allergol Clin immunol 1997;7:340-2.
8. Global initiative for Asthma. Global strategy for Asthma Management and Prevention.
9. NHLBI/WHO. Workshop Report. NIH Publication No 02-3659. January, 1995 (revision 2000.):119-32.
10. Vukelić B. Glukokortikosteroidi u bronhalnoj astmi djeteta: danaśnje stanje. Medicina 1991;27:1-13.
11. Barnes P, Holgate S, Latainen L, Pauwels R. Asthma mechanisms, determinants of severity and treatment: the role of nedocromil sodium. Clin Exp Allergy 1995;25:771-87.
12. Richards I, Shields S, Griffin R, Fidler S, Dunn C. Novel steroid-based inhibitors of lung inflammation. Clin Exp Allergy 1992;22:432-9.
13. Brogden RN, Speight TM, Avery GS. Sodium cromoglycate (Cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use. Drugs 1974;7:164-282.
14. Brodgen RN, Heal RC, Speight TM, Avery GS. Beclomethasone dipropionate: a reappraisal of its pharmacokinetic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs 1984;28:99-126.
15. Boe J, Bakke P, Rodolen T, Skovlund E, Gulsvik A. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Eur Respir J 1994;7:2179-84.
16. Howarth P, Braddin P, Monitefort S, Peroni D, Ukanović R, Carrol M, Holgate S. Mucosal inflammation and asthma. An J Respir Crit Care Med 1994;150:518-22.
17. Laitinen L, Laitinen A, Maahtela T. Airway mucosal inflammation even in patient newly diagnosed asthma. Am Rev Respir Dis 1993;147:697-704.
18. Frigas E, Motojima S, Gleich G. The eosinophilic injury to the mucosa of the airways in the pathogenesis of bronchial asthma. Eur Respir J 1991;13:123-35.
19. Stipić-Marković A, Kljajić-Turkalj M, Tudorić N, Čvorišec B. Imunosni mehanizmi u alergijskim bolestima dišnog sustava. Medicus 1997;6(1):16-26.
20. Lodrup-Carlsen K, Halvorsen R, Ehlstedt S, Carlsen K. Eosinophil cationic protein and tidal flow volume loops in children 0-2 years of age. Eur Respir J 1995;8:1148-54.
21. Phillips G. Structure-activity relationship of topically active steroids: the selection of fluticasone dipropionate. Respir Med 1998;84(Suppl A):19-23.
22. Adcock I, Gelder C, Shirasaki H, Yacoub M, Barnes P. Effect of steroids on transcription factor in human lung. Am Rev Respir Dis 1992;145:A834.
23. Venge P, Henriksen J, Dahl R. Eosinophils in exercise-induced asthma. J Allergy Clin Immunol 1991;88:699-704.
24. Bousquet J, Chanez P, Lacoste JY, Baruen G, Chavanian N, Enander I. Eosinophil activitation in asthma. N Eng J Med 1990;323:1033-9.
25. Kristjansson S, Shimizu T, Strannegard IL, Wennergren G. Eosinophil cationic protein, myeloperoxidase and tryptase in children with asthma and atopic dermatitis. Pediatr Allergy Immunol 1994;5:223-9.
26. Hallgren R, Feltius N, Svenson K, Venge P. Eosinophil involvement in rheumatoid arthritis as reflected by elevated serum levels of eosinophil cationic protein. Clin Exp Immunol 1985;59:539-46.
27. Koler Dy Gotz M, Eichler I, Urbanke R. Eosinophilic activation in cystic fibrosis. Thorax 1994;49:496-9.
28. Karawajezyk M, Paulsen K, Peterson CGB, Eklund E, Venge P. The differential release of eosinophil granule proteins. Studies on patients with acute bacterial and viral infections. Clin Exp Allergy 1995;25:713-9.
29. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first years of life. N Engl J Med 1995;332:133-7.
30. Agertoft L, Pedersen S. Affects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-81.
31. Van den Berg NJ, Ossip MS, Hederos CA, Antilla H, Ribeiro BL, Davies PI. Salmeterol (Fluticasone Propionate 50/100 ug) in combination in a Diskus TM Inhaler (Steroide TM) is effective and safe in children with asthma. Pediatric Pulmonology 2000;30:97-105.
32. Boznasky A, Zaryczanski J, Hebrowska A, Latkowska A. Eosinophil cationic protein in serum from wheezing children. J Inves Allergol Clin Immunol 1997;7:461.
33. Wilson NM, James A, Uasuf C, Payne DN, Hablas H, Agrofioti C, Bush A. Asthma severity and inflammation markers in children. Pediatric Allergy & Immunilogy 2001;12:125-32.
34. Juntunenbackman K, Jarvinen P, Sorva R. Serum eosinophil cationic protein during treatment of asthma in children. Journal of Allergy & Clinical Immunology 1993;92(1 Part 1):34-8.